Alaunos Therapeutics reported $4K in Current Liabilities for its fiscal quarter ending in October of 2024.


Current Liabilities Change Date
Adcock Ingram Holdings ZAR 2.81B 279.84M Dec/2024
Alaunos Therapeutics USD 4K 822K Oct/2024
Amgen USD 20.48B 2.53B Jun/2025
AstraZeneca USD 33.54B 4.41B Jun/2025
Baxter International USD 3.48B 3.03B Mar/2025
Biogen USD 3.18B 2.11B Jun/2025
Bioline Rx USD 15.48M 1.45M Jun/2025
Bristol-Myers Squibb USD 27.53B 3.46B Jun/2025
Celltrion KRW 3.4T 216.25B Mar/2025
Corcept Therapeutics USD 144.66M 1.6M Jun/2025
Cspc Pharmaceutical CNY 9.63B 801.28M Dec/2024
Dianthus Therapeutics USD 20.09M 1.64M Jun/2025
Divis Laboratories Ltd 14.52B 1.61B Mar/2025
Gilead Sciences USD 11.19B 1.15B Jun/2025
GlaxoSmithKline GBP 20.38B 453M Jun/2025
Incyte USD 1.28B 608.18M Jun/2025
Ionis Pharmaceuticals USD 897.24M 646.94M Jun/2025
J&J USD 56.9B 6.58B Mar/2025
Kangmei Pharma CNY 5.75B 64.58M Jun/2025
Knight Therapeutics CAD 118.15M 12.32M Sep/2024
Laboratorios Farma EUR 186.51M 29.86M Jun/2025
Malin Corporation EUR 1000K 500K Dec/2024
Medical Developments International AUD 6.37M 3.17M Dec/2024
Merck USD 26.04B 863M Jun/2025
Neuren Pharmaceuticals AUD 45.76M 36.79M Dec/2024
Novartis USD 31.71B 95M Jun/2025
Organigram Holdings CAD 107.28M 38.32M Jun/2025
Pfizer USD 37.73B 1.27B Jun/2025
Pharma Mar EUR 87.78M 8.29M Jun/2025
PTC Therapeutics USD 627.81M 32.42M Jun/2025
Qiagen NV USD 1.13B 611.37M Jun/2025
Regeneron Pharmaceuticals USD 3.67B 100.4M Jun/2025
Roche Holding CHF 27.02B 424M Dec/2024
Sartorius EUR 1.55B 72.7M Jun/2025
Sino Biopharmaceutical CNY 19.56B 2.39B Dec/2024
TG Therapeutics USD 171.89M 11.68M Jun/2025
Tilray USD 278.52M 15.02M Nov/2024
Zz Pientze Pharmaceu 3.2B 878.89M Jun/2025